Northrop Grumman to Participate in the 13th Annual Morgan Stanley Laguna Conference

Northrop Grumman to Participate in the 13th Annual Morgan Stanley Laguna Conference

Northrop Grumman Corporation (NYSE: NOC) will participate in the 13 th Annual Morgan Stanley Laguna Conference on Thursday, September 11. Kathy Warden, chair, chief executive officer and president, will present beginning at 12:15 p.m. Eastern time. The presentation will be webcast live at http:investor.northropgrumman.com .

Northrop Grumman is a leading global aerospace and defense technology company. Our pioneering solutions equip our customers with the capabilities they need to connect and protect the world, and push the boundaries of human exploration across the universe. Driven by a shared purpose to solve our customers' toughest problems, our employees define possible every day.

Note: Statements to be made at the conference, including in the presentation and in any accompanying materials, contain or may contain statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "will," "expect," "anticipate," "intend," "may," "could," "should," "plan," "strategy," "project," "forecast," "achieve," "believe," "estimate," "guidance," "outlook," "trends," "goals," "confident," "on track" and similar expressions generally identify these forward-looking statements. These forward-looking statements speak only as of the date when made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements after the date of the conference, except as required by applicable law. Forward-looking statements are not guarantees of future performance and inherently involve a wide range of risks and uncertainties that are difficult to predict. A discussion of these risks and uncertainties is contained in the Company's filings with the Securities and Exchange Commission.

Contact:  News Bureau
newsbureau@ngc.com

Todd Ernst (Investors)
todd.ernst@ngc.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

NOC
The Conversation (0)
TSX Venture Exchange Stock Maintenance Bulletins

TSX Venture Exchange Stock Maintenance Bulletins

TSX VENTURE COMPANIES

BULLETIN V2024-0267

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Next Super Stocks on the Move: Tetra Bio-Pharma, Red Light Holland, FansUnite, and Skylight Health

Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK livestream investor conferences, and investor "LiveChats" on social media streams. Over 170,000 investors have participated in Wall Street Reporter's livestream events in the past 30 days.

Red Light Holland (OTC: TRUFF) (CSE: TRIP) CEO Todd Shapiro: "Psychedelics is Next Billion Dollar Market Opportunity"

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada’s First Generic Thyroid Medication

Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada’s First Generic Thyroid Medication

Genix Pharmaceuticals Corporation (TSXV: GENX) (“GENIX” or the “Company“) is pleased to announce that it has entered into an exclusive Canadian licensing and supply agreement (the “Agreement”) with Acme Generics LLP (“ACME”) for the manufacture, sale, marketing and distribution of Canada’s first available generic version of Synthroid® (Levothyroxine sodium), a widely prescribed treatment for hypothyroidism.

Currently sold by Mylan Pharmaceuticals, Synthroid® is the largest volume prescription drug sold in Canada with nearly 20 million prescriptions written in 2019 (www.IQVIA.com). Estimated 2020 sales in Canada is over $200 million.

Keep reading...Show less

Latest Press Releases

Related News

×